INVST’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.4M Buy
8,643
+3,381
+64% +$3.45M 1.01% 26
2026
Q1
$4.84M Sell
5,262
-1,602
-23% -$1.62M 0.55% 42
2025
Q4
$7.38M Buy
6,864
+3,494
+104% +$3.34M 0.8% 35
2025
Q3
$2.57M Sell
3,370
-84
-2% -$62.5K 0.29% 64
2025
Q2
$2.69M Buy
3,454
+166
+5% +$129K 0.34% 57
2025
Q1
$2.72M Sell
3,288
-2,291
-41% -$1.91M 0.37% 58
2024
Q4
$4.31M Buy
5,579
+27
+0.5% +$22.4K 0.52% 46
2024
Q3
$4.92M Buy
5,552
+189
+4% +$170K 0.6% 40
2024
Q2
$4.9M Sell
5,363
-52
-1% -$41.6K 0.54% 43
2024
Q1
$4.12M Sell
5,415
-218
-4% -$155K 0.49% 45
2023
Q4
$3.97M Buy
5,633
+789
+16% +$461K 0.51% 43
2023
Q3
$2.6M Buy
4,844
+6
+0.1% +$3.09K 0.38% 46
2023
Q2
$2.27M Buy
4,838
+45
+0.9% +$18.9K 0.33% 43
2023
Q1
$1.87M Buy
4,793
+4,132
+625% +$1.39M 0.29% 45
2022
Q4
$227K Sell
661
-74
-10% -$26.2K 0.04% 151
2022
Q3
$238K Buy
735
+36
+5% +$11.4K 0.04% 149
2022
Q2
$213K Buy
+699
New +$210K 0.03% 166

Other funds holding LLY

INVST's LLY Position: Q2 2026 in Review

INVST increased its Eli Lilly (LLY) stake by 64% in Q2 2026, buying an estimated $3.45M and bringing the position to 8,643 shares worth $10.4M. The position accounts for 1.01% of the portfolio, ranked #26.

INVST first reported a position in LLY in Q2 2022 and has held it in 17 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • INVST held 8,643 shares of Eli Lilly worth $10.4M as of Q2 2026.
  • INVST bought 3,381 Eli Lilly shares in Q2 2026, an estimated $3.45M.
  • Eli Lilly made up 1.01% of INVST's portfolio in Q2 2026, its #26 holding.
  • INVST first reported a position in Eli Lilly in Q2 2022 and has held it in 17 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on INVST's 13F filing for Q2 2026, filed 14 Aug 2026.